Skip to main content
logo
Aspira Pathlab & Diagnostics Limited (BOM:540788)
India flag India · Delayed Price · Currency is INR
90.05
-1.80 (-1.96%)
At close: Aug 21, 2026

BOM:540788 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
260.23249.82219.99132.05144.57195.42
Revenue Growth
15.09%13.56%66.60%-8.66%-26.02%28.52%
Gross Profit
107.16103.4997.0934.1755.9499.8
Operating Income
-4.77-0.7520.63-27.260.0847.38
Net Income
-4.080.5120.23-26.72-0.8944.59
Earnings Per Share
-0.410.051.97-2.60-0.094.33
EPS Growth
--97.46%---198.62%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
16.816.821.4413.8423.4916.44
Total Debt
33.2233.2231.9627.8233.1439.22
Net Cash (Debt)
-16.42-16.42-10.52-13.98-9.64-22.78
Net Cash Growth
------
Net Cash Per Share
-1.63-1.60-1.02-1.36-0.94-2.21

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-14.5418.2710.54-0.1220.31
Capital Expenditures
--6.96-3.44-2.62-1.31-5.99
Free Cash Flow
-7.5814.837.92-1.4314.32
Free Cash Flow Growth
--48.89%87.32%---74.19%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
41.18%41.43%44.14%25.88%38.69%51.07%
Operating Margin
-1.83%-0.30%9.38%-20.64%0.05%24.24%
Pretax Margin
-1.57%0.21%9.19%-20.24%-0.61%22.82%
Profit Margin
-1.57%0.21%9.19%-20.24%-0.61%22.82%
FCF Margin
-3.03%6.74%6.00%-0.99%7.33%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-1120.5943.37--14.96
P/FCF Ratio
122.3075.8559.1640.31-46.56
PS Ratio
3.582.303.992.421.983.41